Platform to evaluate patient’s biological reactions to SARS-CoV2 infection
-
End-to-end disease model constructionOur novel platform can generate phenotypically validated disease human iPSC models in one integrated process
-
Innovation by designWe generate bespoke cell models tailored to partner project specific requirements
-
Trusted partnerWe collaborate and integrate with your team to deliver world-class science
Leader focused on delivering phenotypically relevant cell models
We are a trusted partner for scientists operating in the drug discovery and cell modeling space
End-to-end partners in your drug discovery journey
Our dedicated, flexible working approach means we work closely with our clients at all times to deliver exemplary results
Accelerate your research with our products
The provision of high quality human-like cell products with a mature phenotype enables you to accelerate your research and optimize your workflow
-
LiverDefiniGEN's human iPSC platform generates high quality wild-type and diseased cell models. In addition our platform allows us to generates custom disease modelled hepatocytesLearn more
-
IntestineWe can produce human iPSC-derived intestinal organoids that provide a unique in vitro system to model the human intestine. In addition we have a monolayer format to study intestinal permeabilityLearn more
-
PancreasOur technology platform produces human iPSC-derived pancreatic beta cells with a dose dependent glucose sensitive insulin secretion (GSIS) response. We also provide monogenic and complex diabetes disease model variantsLearn more